These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29480208)

  • 1. A Genetic Study of Psychosis in Huntington's Disease: Evidence for the Involvement of Glutamate Signaling Pathways.
    Tsuang DW; Greenwood TA; Jayadev S; Davis M; Shutes-David A; Bird TD
    J Huntingtons Dis; 2018; 7(1):51-59. PubMed ID: 29480208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial aggregation of psychotic symptoms in Huntington's disease.
    Tsuang D; Almqvist EW; Lipe H; Strgar F; DiGiacomo L; Hoff D; Eugenio C; Hayden MR; Bird TD
    Am J Psychiatry; 2000 Dec; 157(12):1955-9. PubMed ID: 11097960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease.
    Ellis N; Tee A; McAllister B; Massey T; McLauchlan D; Stone T; Correia K; Loupe J; Kim KH; Barker D; Hong EP; Chao MJ; Long JD; Lucente D; Vonsattel JPG; Pinto RM; Elneel KA; Ramos EM; Mysore JS; Gillis T; Wheeler VC; Medway C; Hall L; Kwak S; Sampaio C; Ciosi M; Maxwell A; Chatzi A; Monckton DG; Orth M; Landwehrmeyer GB; Paulsen JS; Shoulson I; Myers RH; van Duijn E; Rickards H; MacDonald ME; Lee JM; Gusella JF; Jones L; Holmans P
    Biol Psychiatry; 2020 May; 87(9):857-865. PubMed ID: 32087949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    DeMichele-Sweet MAA; Weamer EA; Klei L; Vrana DT; Hollingshead DJ; Seltman HJ; Sims R; Foroud T; Hernandez I; Moreno-Grau S; Tárraga L; Boada M; Ruiz A; Williams J; Mayeux R; Lopez OL; Sibille EL; Kamboh MI; Devlin B; Sweet RA
    Mol Psychiatry; 2018 Apr; 23(4):963-972. PubMed ID: 28461698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of blood biomarkers for psychosis using convergent functional genomics.
    Kurian SM; Le-Niculescu H; Patel SD; Bertram D; Davis J; Dike C; Yehyawi N; Lysaker P; Dustin J; Caligiuri M; Lohr J; Lahiri DK; Nurnberger JI; Faraone SV; Geyer MA; Tsuang MT; Schork NJ; Salomon DR; Niculescu AB
    Mol Psychiatry; 2011 Jan; 16(1):37-58. PubMed ID: 19935739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.
    Di Maria E; Bonvicini C; Bonomini C; Alberici A; Zanetti O; Gennarelli M
    J Alzheimers Dis; 2009; 18(4):953-60. PubMed ID: 20009237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia.
    DeRosse P; Hodgkinson CA; Lencz T; Burdick KE; Kane JM; Goldman D; Malhotra AK
    Biol Psychiatry; 2007 May; 61(10):1208-10. PubMed ID: 17054920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical, imaging and biological features of psychosis in Han Chinese patients with Huntington's disease.
    Li XY; Gao B; Xie JJ; Bao YF; Dong Y; Wu ZY
    J Psychiatr Res; 2021 Sep; 141():333-338. PubMed ID: 34304037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patients.
    Grigoroiu-Serbanescu M; Herms S; Diaconu CC; Jamra RA; Meier S; Bleotu C; Neagu AI; Prelipceanu D; Sima D; Gherghel M; Mihailescu R; Rietschel M; Nöthen MM; Cichon S; Mühleisen TW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):657-63. PubMed ID: 20230869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial psychiatric presentation of Huntington's disease.
    Lovestone S; Hodgson S; Sham P; Differ AM; Levy R
    J Med Genet; 1996 Feb; 33(2):128-31. PubMed ID: 8929949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses.
    Tandon N; Nanda P; Padmanabhan JL; Mathew IT; Eack SM; Narayanan B; Meda SA; Bergen SE; Ruaño G; Windemuth A; Kocherla M; Petryshen TL; Clementz B; Sweeney J; Tamminga C; Pearlson G; Keshavan MS
    Schizophr Res; 2017 Apr; 182():74-83. PubMed ID: 27789186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial aggregation of schizophrenia-like symptoms in Huntington's disease.
    Tsuang D; DiGiacomo L; Lipe H; Bird TD
    Am J Med Genet; 1998 Jul; 81(4):323-7. PubMed ID: 9674979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G72 gene is associated with susceptibility to methamphetamine psychosis.
    Kotaka T; Ujike H; Okahisa Y; Takaki M; Nakata K; Kodama M; Inada T; Yamada M; Uchimura N; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1046-9. PubMed ID: 19482054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database.
    Kalathur RK; Hernández-Prieto MA; Futschik ME
    BMC Neurol; 2012 Jun; 12():47. PubMed ID: 22741533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 immunoreactivity in peripheral plasma is associated with rs6982890 polymorphism-mediated psychotic symptoms in schizophrenia.
    Wang X; Zhou J; Ding S; Zhang J; Liu Y; Liu Y; Zhao J; Shi H; Liu Q; Song M; Lv L; Li W; Yang Y
    Brain Res Bull; 2024 Oct; 217():111075. PubMed ID: 39255944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree.
    Corrêa BB; Xavier M; Guimarães J
    Clin Pract Epidemiol Ment Health; 2006 Feb; 2():1. PubMed ID: 16480508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
    Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.
    Middle F; Pritchard AL; Handoko H; Haque S; Holder R; Bentham P; Lendon CL
    J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malic enzyme 2 and susceptibility to psychosis and mania.
    Lee BD; Walss-Bass C; Thompson PM; Dassori A; Montero PA; Medina R; Contreras S; Armas R; Ramirez M; Pereira M; Salazar R; Leach RJ; Quezada P; Raventos H; Escamilla MA
    Psychiatry Res; 2007 Feb; 150(1):1-11. PubMed ID: 17258816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between RGS4 variants and psychotic-like experiences in nonclinical individuals.
    de Castro-Catala M; Cristóbal-Narváez P; Kwapil TR; Sheinbaum T; Peña E; Barrantes-Vidal N; Rosa A
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):19-24. PubMed ID: 26910404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.